Results 201 to 210 of about 68,039 (253)
Some of the next articles are maybe not open access.
Mechanism of Action of Indomethacin in Indomethacin-Responsive Headaches
Current Pain and Headache Reports, 2013Indomethacin, as a member of the non-steroidal anti-inflammatory drug class, plays a special role in the treatment of headaches. By definition, it is completely efficacious in the treatment of the primary headache disorders paroxysmal hemicrania and hemicrania continua.
Oliver, Summ, Stefan, Evers
openaire +2 more sources
Pharmacokinetic overview of indomethacin and sustained-release indomethacin
The American Journal of Medicine, 1985Indomethacin has a moderately short half-life, usually requiring dosing twice a day or three times a day. A more convenient once or twice daily regimen is made possible with a sustained-release formulation. Following multiple-dose administration of either sustained-release indomethacin (Indocin SR) or conventional indomethacin, drug accumulation is low.
openaire +2 more sources
Drug and Therapeutics Bulletin, 1965
Indomethacin (Indocid - MSD) is described as a ‘new, non-steroid anti-inflammatory agent with analgesic and antipyretic properties’. It has been supplied to hospitals only since November 1964, but will soon be available for prescription in general practice.
openaire +1 more source
Indomethacin (Indocid - MSD) is described as a ‘new, non-steroid anti-inflammatory agent with analgesic and antipyretic properties’. It has been supplied to hospitals only since November 1964, but will soon be available for prescription in general practice.
openaire +1 more source
American Journal of Ophthalmology, 1972
H E, Henkes, G H, van Lith, L R, Canta
openaire +2 more sources
H E, Henkes, G H, van Lith, L R, Canta
openaire +2 more sources